文献速递泌尿生殖腹部CT

建立多参数肾脏CT算法用于诊断小(≤4 cm)实性肾脏肿块中的透明细胞肾细胞癌

Development of a Multiparametric Renal CT Algorithm for Diagnosis of Clear Cell Renal Cell Carcinoma Among Small (≤ 4 cm) Solid Renal Masses.
PubMed 文献 · AJR Am J Roentgenol · 2022-06-29

本研究回顾性纳入148例小(≤4 cm)实性肾脏肿块患者,基于肾脏肿块CT(平扫、皮髓质期、肾实质期)开发五级CT评分算法,用于诊断透明细胞肾细胞癌。算法包含肿块-皮质皮髓质期衰减比值和异质性评分,观察者间一致性加权κ为0.71,诊断透明细胞肾细胞癌的AUC为0.75(阅片者1)和0.72(阅片者2)。CT评分≥4分时敏感度、特异度和阳性预测值分别为71%、79%和79%(阅片者1)及42%、81%和72%(阅片者2);CT评分≤2分时阴性预测值为85%(阅片者1)和88%(阅片者2)。

要点

  • 五级CT评分算法基于肿块-皮质皮髓质期衰减比值和异质性评分,观察者间一致性加权κ为0.71。
  • CT评分≥4分诊断透明细胞肾细胞癌的敏感度、特异度和阳性预测值分别为71%、79%和79%(阅片者1)及42%、81%和72%(阅片者2)。
  • CT评分≤2分排除透明细胞肾细胞癌的阴性预测值为85%(阅片者1)和88%(阅片者2)。

核心结论

  • 包含肿块-皮质皮髓质期衰减比值和异质性评分的五级肾脏CT算法具有中等观察者间一致性、中等AUC和阳性预测值,以及高阴性预测值,可用于诊断透明细胞肾细胞癌。

研究设计与样本

  • 回顾性研究纳入148例患者(73例男性,75例女性;平均年龄58±12岁)的148个小(≤4 cm)实性(>25%强化组织)肾脏肿块,术前接受肾脏肿块CT(平扫、皮髓质期和肾实质期),检查时间在2016年1月至2019年12月之间。

诊断标准与关键数值

  • 透明细胞肾细胞癌的肿块-皮质皮髓质期衰减比值高于其他诊断(阅片者1:0.84±0.68 vs 0.68±0.65,p=.02;阅片者2:0.75±0.29 vs 0.59±0.25,p=.02)。
  • 透明细胞肾细胞癌的异质性评分高于其他诊断(阅片者1:4.0±1.1 vs 1.5±1.6,p<.001;阅片者2:4.4±0.9 vs 3.3±1.5,p<.001)。
  • 五级诊断算法诊断透明细胞肾细胞癌的AUC为0.75(95%CI,0.68-0.82)(阅片者1)和0.72(95%CI,0.66-0.82)(阅片者2)。
  • CT评分≥4分诊断透明细胞肾细胞癌的敏感度、特异度和阳性预测值分别为71%(95%CI,59-80%)、79%(95%CI,67-87%)和79%(95%CI,67-87%)(阅片者1),以及42%(95%CI,31-54%)、81%(95%CI,70-90%)和72%(95%CI,56-84%)(阅片者2)。
  • CT评分≤2分排除透明细胞肾细胞癌的阴性预测值为85%(95%CI,69-95%)(阅片者1)和88%(95%CI,69-97%)(阅片者2)。

临床应用与阅片要点

  • 五级CT评分算法若经验证,可能成为诊断透明细胞肾细胞癌的有用临床工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. The MRI clear cell likelihood score predicts the likelihood that a renal mass is clear cell renal cell carcinoma (ccRCC). A CT-based algorithm has not yet been established. OBJECTIVE. The purpose of our study was to develop and evaluate a CT-based algorithm for diagnosing ccRCC among small (≤ 4 cm) solid renal masses. METHODS. This retrospective study included 148 patients (73 men, 75 women; mean age, 58 ± 12 [SD] years) with 148 small (≤ 4 cm) solid (> 25% enhancing tissue) renal masses that underwent renal mass CT (unenhanced, corticomedullary, and nephrographic phases) before resection between January 2016 and December 2019. Two radiologists independently evaluated CT examinations and recorded calcification, mass attenuation in all phases, mass-to-cortex corticomedullary attenuation ratio, and heterogeneity score (score on a 5-point Likert scale, assessed in corticomedullary phase). Features associated with ccRCC were identified by multivariable logistic regression analysis and then used to create a five-tiered CT score for diagnosing ccRCC. RESULTS. The masses comprised 53% (78/148) ccRCC and 47% (70/148) other histologic diagnoses. The mass-to-cortex corticomedullary attenuation ratio was higher for ccRCC than for other diagnoses (reader 1: 0.84 ± 0.68 vs 0.68 ± 0.65, p = .02; reader 2: 0.75 ± 0.29 vs 0.59 ± 0.25, p = .02). The heterogeneity score was higher for ccRCC than other diagnoses (reader 1: 4.0 ± 1.1 vs 1.5 ± 1.6, p < .001; reader 2: 4.4 ± 0.9 vs 3.3 ± 1.5, p < .001). Other features showed no difference. A five-tiered diagnostic algorithm including the mass-to-cortex corticomedullary attenuation ratio and heterogeneity score had interobserver agreement of 0.71 (weighted κ) and achieved an AUC for diagnosing ccRCC of 0.75 (95% CI, 0.68-0.82) for reader 1 and 0.72 (95% CI, 0.66-0.82) for reader 2. A CT score of 4 or greater achieved sensitivity, specificity, and PPV of 71% (95% CI, 59-80%), 79% (95% CI, 67-87%), and 79% (95% CI, 67-87%) for reader 1 and 42% (95% CI, 31-54%), 81% (95% CI, 70-90%), and 72% (95% CI, 56-84%) for reader 2. A CT score of 2 or less had NPV of 85% (95% CI, 69-95%) for reader 1 and 88% (95% CI, 69-97%) for reader 2. CONCLUSION. A five-tiered renal CT algorithm, including the mass-to-cortex corticomedullary attenuation ratio and heterogeneity score, had substantial interobserver agreement, moderate AUC and PPV, and high NPV for diagnosing ccRCC. CLINICAL IMPACT. The CT algorithm, if validated, may represent a useful clinical tool for diagnosing ccRCC.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Al Nasibi, Pickovsky, Eldehimi, et al. Development of a Multiparametric Renal CT Algorithm for Diagnosis of Clear Cell Renal Cell Carcinoma Among Small (≤ 4 cm) Solid Renal Masses. AJR Am J Roentgenol. 2022. PMID: 35766532. doi:10.2214/AJR.22.27971

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。